1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
OTC Drugs, Medical Devices and Diagnostics: Global Markets

OTC Drugs, Medical Devices and Diagnostics: Global Markets

  • June 2020
  • 317 pages
  • ID: 5914838
  • Format: PDF
  • BCC Research

Summary

Table of Contents

Report Scope:
This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for OTC drugs, medical devices and diagnostic kits used for self-care and the management of various common diseases.

The report considers only “Western” or modern drugs and excludes any other type of drugs such as alternative therapies. This report covers medical devices and diagnostic kits exempted by the U.S. FDA for OTC use.

This study aims to provide an understanding of the dynamics and forecasts of the OTC drugs, medical devices and diagnostic kits market worldwide and provides key market propositions over a five-year forecast period.

The report covers developed and emerging markets in order to help readers understand -
- Detailed description, including demographics and cost burden, of various diseases including cardiovascular diseases, orthopedic diseases, respiratory disorders, diabetes, obesity, gastrointestinal disorders, sleep disorders, skin disorders, and ENT disorders.
- Detailed description and analysis of current OTC drugs, medical devices and diagnostic kits.
- Market characterization, unmet need, and market size and segmentation (by region, by segment, by diseases).
- The current state of the market and the key markets for its future development.
- Major regional trends.
- Market drivers and restraints.
- Detailed market projections through 2024.
- Global competitive thrust in terms of competition and market shares.
- Key marketed and pipeline (research and development) products along with information about their regulatory status.
- Strategic landscape (mergers and acquisitions).
- Regulatory structure: new regulations that will influence the development of the OTC drugs, devices and diagnostics market.
- Pricing and reimbursement.
- Observations and conclusions on the future of OTC drugs, medical devices and diagnostics.
- Profiles of market participants and associations.

Report Includes:
- 26 data tables and 22 additional tables
- An overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics
- Analyses of global market trends with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Coverage of various target diseases, including common health disorders and severe chronic diseases where OTC drugs and devices play a key role in the management of diseases
- Assessment of the recent breakthroughs, current research activities, technological hurdles and latest trends related to the field of medical technologies
- Complete understanding about the usage and adoption rate of OTC drugs, devices and diagnostic kits in various regions
- Underlying details of key business opportunities to pivotal stakeholders to expand of business and capture the revenue in the specific verticals to analyze before investing or expanding the horizon within this market
- Competitive landscape encompassing a large chunk of small, medium and large players on both pharmaceutical drugs and medical devices and diagnostics side
- Profile description of leading market players, including 3M, Akron, Bayer AG, Celgene, and Eli Lilly and Co.

Summary:
OTC drugs, medical devices and diagnostics make up a multibillion-dollar business.The market is spread throughout more than 100 countries and is moving into other countries.

Access to OTC drugs, dietary supplements, and medical devices and diagnostics has helped people to take a more active role in the management of their own health and in the treatment of common illnesses such as body pain, infectious illness, headache, fever, cough and cold, and many more.

OTC drugs and supplements such as analgesics, antipyretics, gastrointestinal products, dermatology products, ophthalmic products, dental products, first aid supplies, and smoking cessation products fall under leading therapeutic categories sold over-the-counter. OTC medical devices and diagnostics include self-care of various diseases and other health conditions. Blood pressure monitors, air purification masks, contraceptive devices, contact lenses, glucose monitoring and insulin delivery devices, inhaler pumps (excluding drug), ortho prosthetics, wearable health devices, drug adherence devices, glucose monitoring test kits, and point-of-care (PoC) diagnostics are some of the commonly
used OTC devices for the management of various diseases.

The global market for OTC drugs (e.g., pharmaceutical OTC drugs, nutritional products [vitamin and mineral supplements]) and medical devices and diagnostics was valued at REDACTED in 2019. The market is expected to reach a value of REDACTED by 2024, increasing at a compound annual growth rate (CAGR) of REDACTED from 2019 through 2024. This market growth is fueled by increasing incidence of common diseases and increasing prevalence of chronic diseases, commercialization of OTC products, patent expiry, increasing acceptance of self-care, growing health hygiene, and growing global acceptance of OTC medical devices and diagnostics. However, some key market barriers are lack of
awareness in underdeveloped countries, poor medication adherence, shorter product life cycles for device technologies, regulatory issues (stringent regulatory approval procedure), increasing manufacturing costs, and health disparities in in low-income countries.

In 2019, the U.S. accounted for REDACTED (REDACTED) of the global OTC drugs, medical devices and diagnostics market. The U.S. market should reach REDACTED by 2024, increasing at a CAGR of REDACTED over the five-year forecast period. The U.S. is expected to maintain dominance in the OTC drugs, nutritional products (vitamin and mineral supplements), medical devices and diagnostics segments of the global OTC market. This growth is due to the growing geriatric population, increasing prevalence of chronic diseases, increasing acceptance of self-care, health hygiene, preventive care, continuous technological advancements, increasing investment, incentives for new product development, increasing adoption of wearable device technologies, and the development of adherence systems and software applications.

In 2019, Europe, the Asia-Pacific region and the Rest of the World (ROW) had shares of REDACTED, REDACTED and REDACTED of the global market, with these shares valued at REDACTED, REDACTED and REDACTED, respectively. The Europe, Asia-Pacific and ROW markets should reach REDACTED, REDACTED and REDACTED by 2024, increasing at CAGRs of REDACTED, REDACTED and REDACTED, respectively, over the five -year forecast period.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on